Levisetti Matteo bought CUE
February 20, 2024 · Form 4 insider transaction
Levisetti Matteo bought 25,000 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderLevisetti Matteo
RoleOfficer
CompanyCue Biopharma, Inc. (CUE)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 20, 2024
Filing dateFebruary 22, 2024
Shares owned after25,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On January 17, 2023 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria was deemed satisfied or waived on February 20, 2024 and these shares underlying the option vested in full.